Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The objective of this study is to assess the safety and tolerability of topical ocular PAN-90806 in patients with active, subfoveal choroidal neovascularization associated with neovascular Age-Related Macular Degeneration (AMD).
Epistemonikos ID: d5997c855409718be9094158d07218b89ee97861
First added on: May 11, 2024